A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients
Begoña Pineda, Ángel Díaz‐Lagares, José Alejandro Pérez Fidalgo, Octavio Burgués, Inés González‐Barrallo, Ana B. Crujeiras, Juan Sandoval, Manel Esteller, Aña Lluch, Pîlar Eroles (2019). A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients. , 11(1), DOI: https://doi.org/10.1186/s13148-019-0626-0.
